SCHEMBL8561636

SCHEMBL8561636

CC(=O)Nc1nc[c]o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8560505 0.72
SCHEMBL2139984 0.65
SCHEMBL13272058 0.65
SCHEMBL3262436 0.65
SCHEMBL989627 0.64
SCHEMBL12199271 0.64 CCNE2 (0.44)
SCHEMBL6172380 0.64 L3MBTL1 (0.43)
SCHEMBL3705118 0.61
SCHEMBL8921536 0.61
SCHEMBL6621934 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0366304-B1 Heterocyclic derivatives, process for their preparation and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1998-04-15 EP claimed
US-5166357-A Nitrogen heterocylic compounds used in treatment of dementia in mammals BEECHAM GROUP P.L.C. (GB) 1992-11-24 US claimed
EP-0366304-A2 Heterocyclic derivatives, process for their preparation and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1990-05-02 EP claimed
EP-0366304-B1 Heterocyclic derivatives, process for their preparation and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1998-04-15 EP disclosed
US-5166357-A Nitrogen heterocylic compounds used in treatment of dementia in mammals BEECHAM GROUP P.L.C. (GB) 1992-11-24 US disclosed
EP-0366304-A2 Heterocyclic derivatives, process for their preparation and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1990-05-02 EP disclosed